Effects of Mongolian Medicine Modified Sugmul-7 on Hyperplasia of the Breast

Authors

  • Tong Shan Department of Traditional Medicine, International School of Mongolian Traditional Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  • Tsend-Ayushi Damba Mongolian Medical Research Center, International School of Mongolian Traditional Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  • Enkhtsetseg Jamsranjav Department of Obstetrics and Gynecology, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  • Tuul Khalzaibaast Department of Traditional Medicine, School of Mongolian Traditional Medicine, Mongolian University of Pharmaceutical Sciences, Ulaanbaatar, Mongolia
  • Gong Juhua Department of Pharmacology, Mongolian Medicine and Pharmaceutical School of Inner Mongolian University of Nationalities, Tongliao, China
  • Wu Yuanyuan Department of Pharmacology, Mongolian Medicine and Pharmaceutical School of Inner Mongolian University of Nationalities, Tongliao, China
  • Lingling Department of Pharmacology, Mongolian Medicine and Pharmaceutical School of Inner Mongolian University of Nationalities, Tongliao, China
  • Ang Gelima Department of Pharmacology, Traditional Chinese Medicine, Inner Mongolian University for Nationalities; Tongliao, China
  • Wang Huan Department of Pharmacology, Mongolian Medicine and Pharmaceutical School of Inner Mongolian University for Nationalities, Pharmacology Laboratory of Mongolian Traditional Medicine, Tongliao, China

DOI:

https://doi.org/10.24079/cajms.2021.09.009

Keywords:

Mongolian Medicine, Hyperplasia of the Breast, Endocrine Function, Proteomics

Abstract

Objectives: The aim of this study was to explore the mechanism of regulating the endocrine function of hyperplasia breast in rats with Mongolian Medicine Modified Sugmul-7 (MMMS-7) by Proteomics and provide an experimental basis for its development and clinical application. Methods: Ninety female SD rats were randomly divided into 6 groups: the intact group – the animal group that was injected with neither estradiol, nor progesterone, nor administered Mongolian Medicine Modified Sugmul-7; the negative control group – the group injected with estradiol and progesterone; the positive control group - injected with estradiol, progesterone and administered mastodynon 0.06 g/kg; and the treatment groups – injected with estradiol and progesterone, each in their respective dose groups. After the start of the experiment, each rat except the intact group was intra peritoneally injected with estradiol 25d and progesterone 6d at a standard dose of 0.3 mg / kg for a total of 31 days. Results: Four differential proteins were found through proteomic analysis, namely Ppp3cb, Cacybp, Gstz1, and Nmd3 and their 5 related pathways. Conclusions: The above pathways are all known to be related to the treatment of breast hyperplasia caused by endocrine disorders. Treatment with Mongolian Medicine Modified Sugmul-7 is completed through regulation of the gastrointestinal and endocrine systems.

Abstract
36
PDF
34

Author Biography

Tong Shan, Department of Traditional Medicine, International School of Mongolian Traditional Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia

Department of Surgery, Affiliated Hospital of Inner Mongolian University for Nationalities, Tongliao, China

Downloads

Published

2021-09-30

How to Cite

Shan, T., Damba, T.-A., Jamsranjav, E., Khalzaibaast, T., Juhua, G., Yuanyuan, W., Lingling, Gelima, A., & Huan, W. (2021). Effects of Mongolian Medicine Modified Sugmul-7 on Hyperplasia of the Breast. Central Asian Journal of Medical Sciences, 7(3), 240–251. https://doi.org/10.24079/cajms.2021.09.009

Issue

Vol. 7 No. 3 (2021)

Section

Articles

License

Copyright (c) 2021 Mongolian National University of Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.